Evidence mapPaperPMID 40869412Full record

ArticleInternational journal of molecular sciences2025

Postbiotic pA1c

Deyan Yavorov-Dayliev, Iñaki Iturria, Leyre Iriarte, Miriam Araña, Miguel Barajas, Josune Ayo

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Deyan Yavorov-DaylievGenbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain.ORCID 0000-0002-7901-0695
Iñaki IturriaGenbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain.
Leyre IriarteGenbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain.
Miriam ArañaBiochemistry Area, Health Science Department, Faculty of Health Sciences, Public University of Navarra, 31008 Pamplona, Navarra, Spain.ORCID 0000-0002-5363-896X
Miguel BarajasBiochemistry Area, Health Science Department, Faculty of Health Sciences, Public University of Navarra, 31008 Pamplona, Navarra, Spain.ORCID 0000-0003-4004-1432
Josune AyoGenbioma Aplicaciones S.L., Cein Centro Europeo, Office D3, Pl. Cein, 1-5, Pol. Ind. Mocholí, 31110 Noáin, Navarra, Spain.

Funding

Gobierno de Navarra 0011-1365-2023-000000
6 · The paper itself

Abstract

Cardiometabolic diseases such as obesity, prediabetes (PreD), and type 2 diabetes (T2D) are global health challenges linked to metabolic dysfunction. While probiotics show promise, postbiotics offer advantages in stability, safety, and food incorporation. This study evaluates the postbiotic pA1c

Indexed as

Caenorhabditis elegansInsulin ResistanceObesityPrediabetic StateProbioticsAnimalsCaenorhabditis elegans ProteinsDisease Models, AnimalGlucoseLipid MetabolismOxidative StressCaenorhabditis elegans ProteinsGlucoseC. elegansdiabetesmetabolic syndromeobesitypostbioticsprobiotics

Identifiers

PMID40869412
PMCPMC12386694

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.